NYSE
End-of-day closes; the latest point is the live 15-min-delayed price · split & dividend adjusted · chart by TradingView
Nu Skin Enterprises, Inc. develops and distributes beauty and wellness products worldwide. It provides skin care systems, nutritional supplements, weight management and body shaping systems, and other products. Nu Skin sells its products under the Nu Skin, Pharmanex, and ageLOC brands.
Roles derived from SEC Form 4 filings.
Actuals from SEC filings; YoY vs the year-ago quarter. Analyst estimates & surprise require a data feed (coming soon).
| Line item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Revenue | $2.6B | $2.7B | $2.2B | $2.0B | $1.7B | $1.5B |
| Gross profit | $1.9B | $2.0B | $1.6B | $1.4B | $1.2B | $1.0B |
| Operating income | $257.6M | $234.0M | $110.8M | $48.3M | -$151.6M | $65.8M |
| Net income | $191.4M | $147.3M | $104.8M | $8.6M | -$146.6M | $160.2M |
| Diluted EPS | $3.63 | $2.86 | $2.07 | $0.17 | -$2.95 | $3.18 |
| Operating cash flow | $379.1M | $141.6M | $108.1M | $118.6M | $111.7M | $80.3M |
| Free cash flow | $315.3M | $73.0M | $49.0M | $60.1M | $70.2M | $46.0M |
| Gross margin | 74.5% | 75.0% | 71.7% | 68.9% | 68.2% | 69.4% |
| Operating margin | 10.0% | 8.7% | 5.0% | 2.5% | -8.8% | 4.4% |
| Net margin | 7.4% | 5.5% | 4.7% | 0.4% | -8.5% | 10.8% |
| Line item | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $439.1M | $430.1M | $445.6M | $364.5M | $386.1M | $364.2M | $370.3M | $320.6M |
| Gross profit | $307.2M | $301.5M | $279.1M | $247.0M | $265.7M | $256.7M | $262.0M | $214.5M |
| Operating income | -$125.6M | $18.2M | -$53.1M | -$9.9M | $30.8M | $21.6M | $23.2M | $4.0M |
| Net income | -$118.3M | $8.3M | -$36.1M | $107.5M | $21.1M | $17.1M | $14.5M | $1.8M |
| Diluted EPS | -$2.38 | $0.17 | -$0.73 | $2.14 | $0.43 | $0.34 | $0.27 | $0.04 |
| Operating cash flow | $51.2M | $31.4M | $25.8M | $389,000.00 | $35.8M | $27.5M | $16.6M | -$3.9M |
| Free cash flow | $43.1M | $22.8M | $13.2M | -$13.2M | $35.8M | $17.6M | $5.9M | -$17.6M |
| Gross margin | 70.0% | 70.1% | 62.7% | 67.8% | 68.8% | 70.5% | 70.7% | 66.9% |
| Operating margin | -28.6% | 4.2% | -11.9% | -2.7% | 8.0% | 5.9% | 6.3% | 1.3% |
| Net margin | -26.9% | 1.9% | -8.1% | 29.5% | 5.5% | 4.7% | 3.9% | 0.6% |
Consensus revenue & EPS estimates and price targets will appear here once a forward-estimates data feed is connected.
| Date | Insider | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| 2026-06-10 | WOODBURY EDWINA D | Award | 19 | $5.43 | $103.17 | filing |
| 2026-06-02 | Winett James M | Sale | 7,203 | $5.62 | $40,480.86 | filing |
| 2026-06-01 | WOODBURY EDWINA D | Sale | 7,203 | $5.70 | $41,057.10 | filing |
| 2026-06-01 | Nathanson Laura | Award | 26,643 | $0.00 | $0.00 | filing |
| 2026-06-01 | Zorko Mark A | Award | 26,643 | $0.00 | $0.00 | filing |
| 2026-06-01 | WOODBURY EDWINA D | Award | 26,643 | $0.00 | $0.00 | filing |
| 2026-06-01 | Winett James M | Award | 26,643 | $0.00 | $0.00 | filing |
| 2026-06-01 | Battle Emma S. | Award | 26,643 | $0.00 | $0.00 | filing |
| 2026-06-01 | Thomas Pisano R. | Award | 26,643 | $0.00 | $0.00 | filing |
| 2026-06-01 | CAMPBELL DANIEL W | Award | 26,643 | $0.00 | $0.00 | filing |
| 2026-05-11 | Nathanson Laura | Sale | 2,676 | $6.73 | $18,009.48 | filing |
| 2026-03-11 | WOODBURY EDWINA D | Award | 14 | $7.31 | $102.34 | filing |
| 2026-03-06 | Hatchett Steven Keith· Chief Product Officer | Award | 77,941 | $0.00 | $0.00 | filing |
| 2026-03-06 | Keisel Justin S· EVP, President of Global Sales | Award | 47,059 | $0.00 | $0.00 | filing |
| 2026-03-06 | Clark Chayce David· EVP, COO and CLO | Award | 138,971 | $0.00 | $0.00 | filing |
| 2026-03-06 | Thomas James D· Chief Financial Officer | Award | 114,706 | $0.00 | $0.00 | filing |
| 2026-03-06 | NAPIERSKI RYAN S· President and CEO | Award | 282,353 | $0.00 | $0.00 | filing |
| 2026-02-26 | NAPIERSKI RYAN S· President and CEO | Tax withholding | 124,802 | $8.63 | $1.1M | filing |
| 2026-02-26 | Clark Chayce David· EVP and General Counsel | Tax withholding | 45,502 | $8.63 | $392,682.26 | filing |
| 2026-02-26 | Thomas James D· Chief Financial Officer | Tax withholding | 28,602 | $8.63 | $246,835.26 | filing |
| 2026-02-26 | Hatchett Steven Keith· Chief Product Officer | Tax withholding | 26,001 | $8.63 | $224,388.63 | filing |
| 2026-02-26 | Keisel Justin S· EVP, President of Global Sales | Tax withholding | 13,687 | $8.63 | $118,118.81 | filing |
| 2026-02-15 | NAPIERSKI RYAN S· President and CEO | Tax withholding | 49,037 | $8.36 | $409,949.32 | filing |
| 2026-02-15 | Clark Chayce David· EVP and General Counsel | Tax withholding | 17,947 | $8.36 | $150,036.92 | filing |
| 2026-02-15 | Thomas James D· Chief Financial Officer | Tax withholding | 11,725 | $8.36 | $98,021.00 | filing |
Showing the latest 25 transactions — full history in the linked SEC filings.
Fundamentals & filings from SEC EDGAR. Prices adjusted for splits & dividends. Not investment advice.